• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Eli Lilly & Co (LLY)

Common Stock
Sell: $1,183.74|Buy: $1,183.87|Change: 1.57 (0.13%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Address

Lilly Corporate Center
Indianapolis
IN
USA
46285

Telephone

+1 317 2962884

Website

https://www.lilly.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Eli Lilly and Co Second Quarter Earnings Conference Call for 20272027-08-05T10:00:00
Eli Lilly and Co Second Quarter Earnings Results for 20272027-08-05T00:00:00
Eli Lilly and Co Annual General Meeting for 20272027-05-04T09:30:00
Eli Lilly and Co First Quarter Earnings Conference Call for 20272027-04-30T10:00:00
Eli Lilly and Co First Quarter Earnings Results for 20272027-04-30T00:00:00
Eli Lilly and Co Annual Report for 20262027-02-12T00:00:00
Eli Lilly and Co Fourth Quarter Earnings Conference Call for 20262027-02-04T10:00:00
Eli Lilly and Co Fourth Quarter Earnings Results for 20262027-02-04T00:00:00
Eli Lilly and Co Third Quarter Earnings Conference Call for 20262026-10-29T10:00:00
Eli Lilly and Co Third Quarter Earnings Result for 20262026-10-29T00:00:00
Morgan Stanley 24th Annual Global Healthcare Conference2026-09-14T13:50:00

Previous key dates

NameKey Date
Morgan Stanley 24th Annual Global Healthcare Conference2026-09-14T13:50:00
Eli Lilly and Co Second Quarter Earnings Conference Call for 20262026-08-05T10:00:00
Eli Lilly and Co Second Quarter Earnings Result for 20262026-08-05T00:00:00
Goldman Sachs 47th Annual Global Healthcare Conference2026-06-09T15:20:00
Investor event2026-06-06T18:00:00
Eli Lilly and Co Annual General Meeting for 20262026-05-04T09:30:00
Eli Lilly and Co First Quarter Earnings Conference Call for 20262026-04-30T10:00:00
Eli Lilly and Co First Quarter Earnings Result for 20262026-04-30T00:00:00
TD Cowen 46th Annual Health Care Conference2026-03-02T15:10:00
Eli Lilly and Co Annual Report for 20252026-02-12T00:00:00
Eli Lilly and Co Fourth Quarter Earnings Conference Call for 20252026-02-04T10:00:00
Eli Lilly and Co Fourth Quarter Earnings Result for 20252026-02-04T00:00:00
44th Annual J.P. Morgan Healthcare Conference2026-01-13T17:15:00
Citi's 2025 Global Healthcare Conference2025-12-02T10:30:00
Eli Lilly and Co Third Quarter Earnings Conference Call for 20252025-10-30T10:00:00
Eli Lilly and Co Third Quarter Earnings Result for 20252025-10-30T00:00:00
Bernstein's 2nd Annual Healthcare Forum2025-09-25T08:00:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-08T09:15:00
Wells Fargo 20th Annual Healthcare Conference2025-09-05T09:30:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.